These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27525312)

  • 21. Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase.
    Iwakiri Y
    Clin Mol Hepatol; 2015 Dec; 21(4):319-25. PubMed ID: 26770919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
    Popov Y; Patsenker E; Stickel F; Zaks J; Bhaskar KR; Niedobitek G; Kolb A; Friess H; Schuppan D
    J Hepatol; 2008 Mar; 48(3):453-64. PubMed ID: 18221819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine vasopressin increases iNOS-NO system activity in cardiac fibroblasts through NF-kappaB activation and its relation with myocardial fibrosis.
    Fan YH; Zhao LY; Zheng QS; Dong H; Wang HC; Yang XD
    Life Sci; 2007 Jul; 81(4):327-35. PubMed ID: 17604059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of nitric oxide and KATP channel in the protective effect mediated by nicorandil in bile duct ligation-induced liver fibrosis in rats.
    Mohamed YS; Ahmed LA; Salem HA; Agha AM
    Biochem Pharmacol; 2018 May; 151():135-142. PubMed ID: 29522711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of inducible nitric oxide synthase in the liver of bile duct-ligated Wistar rats with modulation by lymphomononuclear cells.
    Arriero MM; López-Farré A; Fryeiro O; Rodríguez-Feo JA; Velasco S; García-Durán M; Fortes J; De La Pinta JC; Muñoz LE; Celdrán A
    Surgery; 2001 Mar; 129(3):255-66. PubMed ID: 11231453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inducible nitric oxide synthase is not essential for the development of fibrosis and liver damage induced by CCl4 in mice.
    Moreno MG; Muriel P
    J Appl Toxicol; 2006; 26(4):326-32. PubMed ID: 16705756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inducible nitric oxide synthase in the liver: regulation and function.
    Taylor BS; Alarcon LH; Billiar TR
    Biochemistry (Mosc); 1998 Jul; 63(7):766-81. PubMed ID: 9721329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration.
    Aram G; Potter JJ; Liu X; Torbenson MS; Mezey E
    Hepatology; 2008 Jun; 47(6):2051-8. PubMed ID: 18506890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional Selectivity of a Biased Cannabinoid-1 Receptor (CB
    Liu Z; Iyer MR; Godlewski G; Jourdan T; Liu J; Coffey NJ; Zawatsky CN; Puhl HL; Wess J; Meister J; Liow JS; Innis RB; Hassan SA; Lee YS; Kunos G; Cinar R
    ACS Pharmacol Transl Sci; 2021 Jun; 4(3):1175-1187. PubMed ID: 34151207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of nitric oxide in the regulation of fibrogenic factors in experimental liver fibrosis in mice.
    Leung TM; Fung ML; Liong EC; Lau TY; Nanji AA; Tipoe GL
    Histol Histopathol; 2011 Feb; 26(2):201-11. PubMed ID: 21154234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exogenous nitric oxide enhances the prophylactic effect of aminoguanidine, a preferred iNOS inhibitor, on bleomycin-induced fibrosis in the lung: Implications for the direct roles of the NO molecule in vivo.
    Chen C; Yun XJ; Liu LZ; Guo H; Liu LF; Chen XL
    Nitric Oxide; 2017 Nov; 70():31-41. PubMed ID: 28757441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The genetic inactivation of inducible nitric oxide synthase (iNOS) intensifies fibrosis and oxidative stress in the penile corpora cavernosa in type 1 diabetes.
    Ferrini MG; Rivera S; Moon J; Vernet D; Rajfer J; Gonzalez-Cadavid NF
    J Sex Med; 2010 Sep; 7(9):3033-44. PubMed ID: 20626593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inducible nitric oxide synthase inhibition by 1400W limits pain hypersensitivity in a neuropathic pain rat model.
    Staunton CA; Barrett-Jolley R; Djouhri L; Thippeswamy T
    Exp Physiol; 2018 Apr; 103(4):535-544. PubMed ID: 29441689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of inducible nitric oxide synthase and nitric oxide during hepatic injury and fibrogenesis.
    Rockey DC; Chung JJ
    Am J Physiol; 1997 Jul; 273(1 Pt 1):G124-30. PubMed ID: 9252518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture.
    Okamoto I; Abe M; Shibata K; Shimizu N; Sakata N; Katsuragi T; Tanaka K
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):716-22. PubMed ID: 10934111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice.
    McKim SE; Gäbele E; Isayama F; Lambert JC; Tucker LM; Wheeler MD; Connor HD; Mason RP; Doll MA; Hein DW; Arteel GE
    Gastroenterology; 2003 Dec; 125(6):1834-44. PubMed ID: 14724835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome.
    Knani I; Earley BJ; Udi S; Nemirovski A; Hadar R; Gammal A; Cinar R; Hirsch HJ; Pollak Y; Gross I; Eldar-Geva T; Reyes-Capo DP; Han JC; Haqq AM; Gross-Tsur V; Wevrick R; Tam J
    Mol Metab; 2016 Dec; 5(12):1187-1199. PubMed ID: 27900261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy.
    Hinden L; Udi S; Drori A; Gammal A; Nemirovski A; Hadar R; Baraghithy S; Permyakova A; Geron M; Cohen M; Tsytkin-Kirschenzweig S; Riahi Y; Leibowitz G; Nahmias Y; Priel A; Tam J
    J Am Soc Nephrol; 2018 Feb; 29(2):434-448. PubMed ID: 29030466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of pro-inflammatory cytokine release by selective inhibition of inducible nitric oxide synthase in mucosal explants from patients with ulcerative colitis.
    Kankuri E; Hämäläinen M; Hukkanen M; Salmenperä P; Kivilaakso E; Vapaatalo H; Moilanen E
    Scand J Gastroenterol; 2003 Feb; 38(2):186-92. PubMed ID: 12678336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene transfer of inducible nitric oxide synthase complementary DNA regresses the fibrotic plaque in an animal model of Peyronie's disease.
    Davila HH; Magee TR; Vernet D; Rajfer J; Gonzalez-Cadavid NF
    Biol Reprod; 2004 Nov; 71(5):1568-77. PubMed ID: 15240426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.